Athenex - Stock Price History | ATNX

Historical daily share price chart and data for Athenex since 2021 adjusted for splits. The latest closing stock price for Athenex as of October 27, 2021 is 2.52.
  • The all-time high Athenex stock closing price was 21.00 on July 10, 2019.
  • The Athenex 52-week high stock price is 15.00, which is 495.2% above the current share price.
  • The Athenex 52-week low stock price is 2.48, which is 1.6% below the current share price.
  • The average Athenex stock price for the last 52 weeks is 6.77.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Athenex Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 11.8693 15.8000 15.8500 5.7100 11.0600 -27.57%
2019 13.9238 12.7700 21.0000 9.4400 15.2700 20.33%
2018 15.8316 15.8700 19.9700 10.2450 12.6900 -20.19%
2017 16.8324 12.5600 19.5100 12.5600 15.9000 0.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.275B $0.144B
Athenex, Inc. is a clinical stage biopharmaceutical company. It engaged in the discovery and development of drugs for the treatment of cancer. The company's platform including an Oncology Innovation Platform, a Commercial Platform and a Global Supply Chain Platform. It operates primarily in Buffalo and Clarence, New York, Cranford, New Jersey, Houston, Texas, Chicago, Illinois, Hong Kong and Taipei Taiwan. Athenex, Inc. is based in Buffalo, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.416B 8.62
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.526B 21.21
Biohaven Pharmaceutical Holding (BHVN) United States $9.249B 0.00
Emergent Biosolutions (EBS) United States $2.705B 6.53
Arcus Biosciences (RCUS) United States $2.404B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.873B 0.00
Myovant Sciences (MYOV) United Kingdom $1.831B 0.00
Zymeworks (ZYME) Canada $1.080B 0.00
Ambrx Biopharma (AMAM) United States $0.464B 0.00
SQZ Biotechnologies (SQZ) United States $0.372B 0.00
Enzo Biochem (ENZ) United States $0.161B 15.86